Livingbridge has sold a minority stake in CREATE Fertility
CREATE Fertility is a national provider of fertility services in the UK and a pioneer in natural and mild IVF techniques, which are less drug intensive approaches to IVF. Its first IVF centre was opened in 2008 and operated for five years as a single site. In 2013, the decision was made to expand the business to make natural and mild IVF accessible nationally. Livingbridge was selected as a minority investor to help facilitate this expansion. The business now operates eight UK clinics, including innovative low-cost clinic ‘abc IVF’, which combined with their international operations, means CREATE now performs more than 4,000 treatments each year.
Lincoln acted as the exclusive financial adviser to Livingbridge.
Matthew Lee, Managing Director and head of Lincoln International’s UK Healthcare Group, commented, “We are delighted to have advised on this transaction, Lincoln’s 2nd in the IVF sector in the last few months. Having closely followed the expansion of CREATE over the past few years, we are pleased to have supported Livingbridge on their exit.”
Matthew and the Lincoln team really know the IVF sector well and were super responsive in delivering our exit, from establishing an equitable valuation through to deal completion. Our investment in CREATE has been an excellent one and we wish the team and business every success in the future.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by an undisclosed strategic buyer
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP